aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
5.35
+0.21 (4.09%)
Jun 5, 2025, 4:00 PM - Market closed
aTyr Pharma Employees
As of December 31, 2024, aTyr Pharma had 65 total employees, including 56 full-time and 9 part-time employees. The number of employees increased by 6 or 10.17% compared to the previous year.
Employees
65
Change (1Y)
6
Growth (1Y)
10.17%
Revenue / Employee
n/a
Profits / Employee
-$975,569
Market Cap
476.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ATYR News
- 1 day ago - aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) - GlobeNewsWire
- 16 days ago - aTyr Pharma to Present at Upcoming Investor Conferences - GlobeNewsWire
- 17 days ago - aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference - GlobeNewsWire
- 20 days ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - aTyr Pharma Advances ATYR0101 to IND Candidate Stage for Pulmonary Fibrosis - GlobeNewsWire
- 4 weeks ago - aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 2 months ago - aTyr Pharma to Participate in April Investor Conferences - GlobeNewsWire